GlobeNewswire Inc.··Rosen Law FirmAtara Biotherapeutics Hit With Securities Lawsuit Over Tabelecleucel Drug Claims
Rosen Law Firm sues Atara Biotherapeutics for allegedly misrepresenting tabelecleucel drug's regulatory prospects and manufacturing capabilities to investors between May 2024 and January 2026. Lead plaintiff deadline set for May 22, 2026.
ATRAsecurities class actionmisleading statements